Cours Windtree Therapeutics Inc Nasdaq
Actions
US97382D1054
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 2,52 M 2,28 M |
---|---|---|---|---|---|
Résultat net 2024 * | -21 M -19 M | Résultat net 2025 * | -29 M -26,23 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-0,28
x | PER 2025 * |
-0,42
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 95,34% |
Dernier transcript sur Windtree Therapeutics Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/02/16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/03/20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/02/21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/06/23 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/02/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,69% | 47,9 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,7 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+0,17% | 12,15 Md | |
+28,07% | 12,14 Md | |
-1,24% | 11,99 Md |